Ultragenyx Pharmaceutical (RARE) Shares Outstanding (Entity) (2013 - 2026)

Ultragenyx Pharmaceutical (RARE) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Ultragenyx Pharmaceutical 2.61 Bn 2.33 Bn 180.00 Mn 98.60 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 98.60 Mn
Mar 31, 2026 98.30 Mn
Dec 31, 2025 96.60 Mn
Sep 30, 2025 96.44 Mn
Jun 30, 2025 96.35 Mn
Mar 31, 2025 93.90 Mn
Dec 31, 2024 92.48 Mn
Sep 30, 2024 92.30 Mn
Jun 30, 2024 92.14 Mn
Mar 31, 2024 83.09 Mn
Dec 31, 2023 82.32 Mn
Sep 30, 2023 72.17 Mn
Jun 30, 2023 71.47 Mn
Mar 31, 2023 70.66 Mn
Dec 31, 2022 70.20 Mn
Sep 30, 2022 70.08 Mn
Jun 30, 2022 70.01 Mn
Mar 31, 2022 69.80 Mn
Dec 31, 2021 69.34 Mn
Sep 30, 2021 67.96 Mn